Delivery Order SPE2DB20D1100-SPE2DB25FE6B9
Award Date 9/11/25
Potential Completion Date 10/2/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $25,556.44 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Attruby 356 mg tablets (28-count packaging). This is a firm fixed price, non-set-aside competitive delivery order with performance scheduled to conclude by September 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12.78K delivery order to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count units) under a firm fixed-price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Attruby 356 mg tablets (28-count packaging). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 16, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,778.22 to AmerisourceBergen Drug Corp for ATTRUBY 356 mg tablets (28-count units) on August 22, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,778.22 to AmerisourceBergen Drug Corp for the supply of Attruby 356 mg tablets (28-count package). This firm fixed-price, competitively awarded delivery order was executed on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Attruby 356 mg tablets (28-count units) with a ceiling value of $12,778.22. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-competitive, non-set-aside award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order falls under...
- This is a $12,778.22 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATTRUBY 356 MG TABLET 28S, a pharmaceutical product, with a performance period ending on July 3, 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $75,560.00 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, designated as a non-set-aside competitive award, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $41,762.73 for ORSERDU 345 mg tablets (30-count units) from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 29, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,778.22, is a firm fixed-price delivery order for the supply of ATTRUBY 356 MG TABLET 28S medical products. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...